Search Results

There are 16180 results for: content related to: The clofibrate saga: a retrospective commentary

  1. Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia

    Intervention Review

    The Cochrane Library

    Maryam Gholitabar, Hugh McGuire, Janet Rennie, Donal Manning and Rosalind Lai

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD009017.pub2

  2. You have free access to this content
    Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

    British Journal of Clinical Pharmacology

    Volume 7, Issue 6, June 1979, Pages: 599–603, JC Daubresse, D Daigneux, M Bruwier, A Luyckx and PJ Lefebvre

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1979.tb04649.x

  3. Prediction of stability in pharmaceutical preparations XIX: Stability evaluation and bioanalysis of clofibric acid esters by high-pressure liquid chromatography

    Journal of Pharmaceutical Sciences

    Volume 71, Issue 1, January 1982, Pages: 14–25, Edward R. Garrett and Michael R. Gardner

    Version of Record online : 21 SEP 2006, DOI: 10.1002/jps.2600710105

  4. The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia

    European Journal of Clinical Investigation

    Volume 4, Issue 1, February 1974, Pages: 163–174, A. H. Kissebah, P. W. Adams, P. Harrigan and V. Wynn

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2362.1974.tb00387.x

  5. You have free access to this content
    Fibrates for secondary prevention of cardiovascular disease and stroke

    Intervention Review

    The Cochrane Library

    Deren Wang, Bian Liu, Wendan Tao, Zilong Hao and Ming Liu

    Published Online : 25 OCT 2015, DOI: 10.1002/14651858.CD009580.pub2

  6. The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia

    European Journal of Clinical Investigation

    Volume 4, Issue 3, June 1974, Pages: 163–174, A. H. Kissebah, P. W. Adams, P. Harrigan and Professor V. Wynn

    Version of Record online : 2 MAR 2011, DOI: 10.1111/j.1365-2362.1974.tb02329.x

  7. You have free access to this content
    Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus.

    British Journal of Clinical Pharmacology

    Volume 17, Issue 1, January 1984, Pages: 89–91, K. Murakami, S. Nambu, H. Koh, M. Kobayashi and Y. Shigeta

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1984.tb05005.x

  8. Biomolecular Chemistry of Isopropyl Fibrates

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 4, April 2012, Pages: 1555–1569, Ganesaratnam K. Balendiran, Niharika Rath, Amanda Kotheimer, Chad Miller, Matthias Zeller and Nigam P. Rath

    Version of Record online : 13 JAN 2012, DOI: 10.1002/jps.23040

  9. Pharmacokinetics of Clofibrate and Chlorophenoxy Isobutyric Acid. I. Cross-over Studies on Human Volunteers

    Acta Pharmacologica et Toxicologica

    Volume 36, Issue 4, April 1975, Pages: 353–365, P. T. Männistö, J. Tuomisto, A. Jounela and O. Penttilä

    Version of Record online : 13 MAR 2009, DOI: 10.1111/j.1600-0773.1975.tb00802.x

  10. Control of clofibrate toxicity in uremic hypertriglyceridemia

    Clinical Pharmacology & Therapeutics

    Volume 21, Issue 3, March 1977, Pages: 317–325, Andrew P. Goldberg, Donald J. Sherrard, Linda B. Haas and John D. Brunzell

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977213317

  11. You have free access to this content
    Effect of clofibrate on glucose tolerance in maturity onset diabetes.

    British Journal of Clinical Pharmacology

    Volume 4, Issue 4, August 1977, Pages: 455–458, D Barnett, JG Craig, DS Robinson and MP Rogers

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1977.tb00761.x

  12. β-Oxidation of Valproate

    Epilepsia

    Volume 30, Issue 6, December 1989, Pages: 790–796, Kevin M. Koch, Kathryn S. Prickett, Albert W. Rettenmeier, Thomas A. Baillie and René H. Levy

    Version of Record online : 5 NOV 2007, DOI: 10.1111/j.1528-1157.1989.tb05339.x

  13. Clofibrate microcapsules: Preparation and release rate studies

    Journal of Pharmaceutical Sciences

    Volume 65, Issue 10, October 1976, Pages: 1476–1479, P. L. Madan, Devendra K. Madan and J. C. Price

    Version of Record online : 18 SEP 2006, DOI: 10.1002/jps.2600651015

  14. Lack of Effect of Cholestyramine on the Pharmacokinetics of Clofibrate in Man

    European Journal of Clinical Investigation

    Volume 5, Issue 2, April 1975, Pages: 177–185, A. Sedaghat and Dr., Jr. E.H. Ahrens

    Version of Record online : 2 MAR 2011, DOI: 10.1111/j.1365-2362.1975.tb02284.x

  15. You have free access to this content
    Increased Biosynthesis of CoA in the Liver of Rats Treated with Clofibrate

    European Journal of Biochemistry

    Volume 98, Issue 1, July 1979, Pages: 223–229, Sverre SKREDE and Ola HALVORSEN

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1432-1033.1979.tb13180.x

  16. TREATMENT OF DIABETIC NEUROPATHY WITH CLOFIBRATE

    Journal of the American Geriatrics Society

    Volume 19, Issue 9, September 1971, Pages: 763–772, Magdalena R. Berenyi, Bernard Straus and Osvaldo E. Miglietta

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1971.tb02426.x

  17. One-year trials with halofenate, clofibrate, and placebo

    Clinical Pharmacology & Therapeutics

    Volume 19, Issue 3, March 1976, Pages: 352–359, Carlos A. Dujovne, Daniel L. Azarnoff, David H. Huffman, Pertti Pentikainen, Aryeh Hurwitz and Don W. Shoeman

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1976193352

  18. Ligand-induced expression of peroxisome proliferator-activated receptor α and activation of fatty acid oxidation enzymes in fatty liver

    European Journal of Clinical Investigation

    Volume 34, Issue 6, June 2004, Pages: 429–435, F. Akbiyik, K. Cinar, E. Demirpence, T. Ozsullu, R. Tunca, R. Haziroglu, C. Yurdaydin, O. Uzunalimoglu and H. Bozkaya

    Version of Record online : 16 JUN 2004, DOI: 10.1111/j.1365-2362.2004.01359.x

  19. Biliary lipid composition during treatment with different hypolipidaemic drugs

    European Journal of Clinical Investigation

    Volume 9, Issue 3, June 1979, Pages: 185–190, BO ANGELIN, KURT EINARSSON and BARBRO LEIJD

    Version of Record online : 20 MAR 2008, DOI: 10.1111/j.1365-2362.1979.tb00921.x

  20. Effects of clofibrate and a fat-modified diet on serum lipids

    Clinical Pharmacology & Therapeutics

    Volume 17, Issue 2, February 1975, Pages: 171–178, Helen B. Brown, Lena A. Lewis and Irvine H. Page

    Version of Record online : 1 FEB 2017, DOI: 10.1002/cpt1975172171